KR101042123B1 - 포유동물에서 염증을 감소시키기 위한 유산균의 선별과용도 - Google Patents

포유동물에서 염증을 감소시키기 위한 유산균의 선별과용도 Download PDF

Info

Publication number
KR101042123B1
KR101042123B1 KR1020077021996A KR20077021996A KR101042123B1 KR 101042123 B1 KR101042123 B1 KR 101042123B1 KR 1020077021996 A KR1020077021996 A KR 1020077021996A KR 20077021996 A KR20077021996 A KR 20077021996A KR 101042123 B1 KR101042123 B1 KR 101042123B1
Authority
KR
South Korea
Prior art keywords
lactobacillus
cells
reuteri
strains
tnfα
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020077021996A
Other languages
English (en)
Korean (ko)
Other versions
KR20070121700A (ko
Inventor
에아몬 콘놀리
Original Assignee
바이오가이아 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이오가이아 에이비 filed Critical 바이오가이아 에이비
Publication of KR20070121700A publication Critical patent/KR20070121700A/ko
Application granted granted Critical
Publication of KR101042123B1 publication Critical patent/KR101042123B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020077021996A 2005-04-15 2006-04-12 포유동물에서 염증을 감소시키기 위한 유산균의 선별과용도 Expired - Lifetime KR101042123B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/107,438 2005-04-15
US11/107,438 US7344867B2 (en) 2005-04-15 2005-04-15 Selection and use of lactic acid bacteria for reducing inflammation in mammals

Publications (2)

Publication Number Publication Date
KR20070121700A KR20070121700A (ko) 2007-12-27
KR101042123B1 true KR101042123B1 (ko) 2011-06-16

Family

ID=37087291

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077021996A Expired - Lifetime KR101042123B1 (ko) 2005-04-15 2006-04-12 포유동물에서 염증을 감소시키기 위한 유산균의 선별과용도

Country Status (16)

Country Link
US (2) US7344867B2 (cg-RX-API-DMAC10.html)
EP (1) EP1868622B1 (cg-RX-API-DMAC10.html)
JP (1) JP4740999B2 (cg-RX-API-DMAC10.html)
KR (1) KR101042123B1 (cg-RX-API-DMAC10.html)
CN (1) CN101160134B (cg-RX-API-DMAC10.html)
AU (1) AU2006234793B2 (cg-RX-API-DMAC10.html)
DK (1) DK1868622T3 (cg-RX-API-DMAC10.html)
ES (1) ES2606765T3 (cg-RX-API-DMAC10.html)
HU (1) HUE032297T2 (cg-RX-API-DMAC10.html)
LT (1) LT1868622T (cg-RX-API-DMAC10.html)
MX (1) MX2007012656A (cg-RX-API-DMAC10.html)
PL (1) PL1868622T3 (cg-RX-API-DMAC10.html)
PT (1) PT1868622T (cg-RX-API-DMAC10.html)
RU (1) RU2378370C2 (cg-RX-API-DMAC10.html)
SI (1) SI1868622T1 (cg-RX-API-DMAC10.html)
WO (1) WO2006110088A1 (cg-RX-API-DMAC10.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080254011A1 (en) * 2007-04-11 2008-10-16 Peter Rothschild Use of selected lactic acid bacteria for reducing atherosclerosis
US20110293710A1 (en) * 2010-02-02 2011-12-01 Delphine Saulnier Immunomodulatory properties of lactobacillus strains
US8785183B2 (en) * 2010-09-21 2014-07-22 Biogaia Ab Active plastic material in oil
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
ES2402014B1 (es) 2011-09-07 2014-02-27 Consejo Superior De Investigaciones Científicas (Csic) Peptido secretado por lactobacillus plantarum con función inmunomoduladora
EP2830599B1 (en) 2012-03-29 2018-08-15 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
HUE042643T2 (hu) 2012-06-04 2019-07-29 Biogaia Ab Lactobacillus reuteri ATCC PTA 6475 csontveszteség
US9907755B2 (en) 2013-03-14 2018-03-06 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
ES2874479T3 (es) * 2014-01-23 2021-11-05 Biogaia Ab Agentes que modulan el dolor gastrointestinal
JP2018510631A (ja) * 2015-03-26 2018-04-19 バイオガイア・エイビーＢｉｏｇａｉａ ＡＢ ヒスタミン産生細菌株及びがんにおけるそれらの使用
US10376563B1 (en) 2016-02-12 2019-08-13 Wisconsin Alumni Research Foundation Methods for systemically delivering polypeptides and microorganisms therefor
HUE062788T2 (hu) 2016-04-15 2023-12-28 Baylor College Medicine Lactobacillus reuteri MM4-1A alkalmazása az autizmus spektrumzavar kezelésében vagy megelõzésében
KR102250597B1 (ko) 2017-11-20 2021-05-11 경희대학교 산학협력단 신규 유산균 및 이의 용도
CN110893195B (zh) * 2019-09-30 2023-03-14 内蒙古伊利实业集团股份有限公司 一种具有缓解肠道炎症功能的副干酪乳杆菌et-22
EP3897836B1 (en) 2019-11-08 2023-08-16 Biogaia AB Serotonin producing bacteria
CN114196581B (zh) * 2020-12-16 2023-06-13 江南大学 缓解高尿酸血症的罗伊氏乳杆菌ccfm1132及应用
WO2023007468A1 (en) 2021-07-30 2023-02-02 Helaina, Inc. Methods and compositions for protein synthesis and secretion
JPWO2023063314A1 (cg-RX-API-DMAC10.html) 2021-10-11 2023-04-20
KR102752058B1 (ko) * 2023-08-25 2025-01-13 전남대학교 산학협력단 락토바실러스 루터리 nchbl-005 균주, 사균체 또는 이의 혼합물을 유효 성분으로 포함하는 염증성 질환 예방, 치료 또는 개선용 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004031368A1 (en) 2002-10-07 2004-04-15 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5458875A (en) * 1990-06-15 1995-10-17 Biogaia Ab In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
US5534253A (en) * 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
US20010049115A1 (en) * 2000-01-17 2001-12-06 Collins John Kevin Vitro model for gastrointestinal inflammation
AU5773600A (en) * 1999-06-30 2001-01-31 Board Of Regents Of The University Of Nebraska, The Method of isolation of regulated virulence determinants from bacterial pathogens
US6953574B2 (en) * 2002-06-21 2005-10-11 Technology Commercialization, Inc. Method for producing a fermented hydrolyzed medium containing microorganisms
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004031368A1 (en) 2002-10-07 2004-04-15 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter

Also Published As

Publication number Publication date
RU2007142174A (ru) 2009-05-20
US7344867B2 (en) 2008-03-18
HK1115730A1 (en) 2008-12-05
KR20070121700A (ko) 2007-12-27
WO2006110088A1 (en) 2006-10-19
EP1868622A4 (en) 2011-11-02
ES2606765T3 (es) 2017-03-27
LT1868622T (lt) 2017-01-10
US20060233775A1 (en) 2006-10-19
DK1868622T3 (en) 2017-01-16
CN101160134B (zh) 2012-08-22
EP1868622A1 (en) 2007-12-26
CN101160134A (zh) 2008-04-09
PL1868622T3 (pl) 2017-04-28
US20080107635A1 (en) 2008-05-08
JP4740999B2 (ja) 2011-08-03
SI1868622T1 (sl) 2017-01-31
PT1868622T (pt) 2016-12-29
AU2006234793A1 (en) 2006-10-19
JP2008538288A (ja) 2008-10-23
EP1868622B1 (en) 2016-09-28
RU2378370C2 (ru) 2010-01-10
MX2007012656A (es) 2007-12-13
HUE032297T2 (en) 2017-09-28
AU2006234793B2 (en) 2010-10-28

Similar Documents

Publication Publication Date Title
US20080107635A1 (en) Selection and use of lactic acid bacteria for reducing inflammation in mammals
CN101171019B (zh) 免疫功能调节剂
Zhang et al. Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-α–induced interleukin-8 production in caco-2 cells
Paturi et al. Immune enhancing effects of Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 in mice
US7678553B2 (en) Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
Tsai et al. Effect of the administration of Lactobacillus paracasei subsp. paracasei NTU 101 on Peyer's patch-mediated mucosal immunity
NO327205B1 (no) Lactobacillus paracasei-stamme, sammensetning inneholdende en slik stamme samt anvendelser derav.
EP2270131A1 (en) Feline probiotic lactobacilli
EP2220210B1 (en) Strains of lactobacillus plantarum as probiotics with immunomodulatory specific effect
KR101277050B1 (ko) 조제유-수유 영아에서 전신 염증을 치료, 예방 또는감소하기 위한, 장쇄 다중불포화 지방산과 병용되는락토바실러스 람노수스 ｇｇ의 용도
EP2332557A1 (en) Probiotic lactic acid bacteria
HK1115730B (en) Selection and use of lactic acid bacteria for reducing inflammation in mammals
McCoy Effects of feeding Lactobacillus reuteri X-18 on blood chemistry and immune parameters in beagle (Canis familiaris) puppies
Link et al. The effect of Bacillus licheniformis on haematological parameters in calves
HK1115067B (en) Immune function modulating agent

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20070922

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20080918

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20101021

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20110531

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20110609

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20110609

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20140321

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20140321

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20150305

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20150305

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20160323

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20160323

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20170406

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20170406

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20180328

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20180328

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20200323

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20210422

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 20220512

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20230517

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20240513

Start annual number: 14

End annual number: 14